Medical materials · News
Motherson To Acquire German G+S
Delhi based Motherson Sumi Systems Ltd has reached an agreement with German insolvency administrators to acquire a running plastics injection molding company, G+S Kunststofftechnik Gmbh (G+S), located near Stuttgart i…
Delhi based Motherson Sumi Systems Ltd has reached an agreement with German insolvency administrators to acquire a running plastics injection molding company, G+S Kunststofftechnik Gmbh (G+S), located near Stuttgart in Germany. The settlement with the insolvency administrator envisages an investment of 2 million euros towards equity and payment to G+S's creditors, spread over a period of three years, the company informed BSE on Friday.
Centre Plans Guideline For Uniform Action Against NSQ Medical Devices
The Central Drugs Standard Control Organisation (CDSCO) has decided to prepare a guideline for uniform action against the manufacture of not of standard quality (NSQ) medical devices, diagnostic reagents, diagnostic kits etc. The guideline would prescribe the exact procedures to be followed and action to be taken against the manufacturers by every state drug controller.
According to official sources, a guideline for NSQ drug is already in place. The current move is to make it more comprehensive by including all kinds of drugs and medical devices that were left out from the existing guideline. A subcommittee of the Drugs Consultative Committee (DCC) has been given the guideline and framing new guidelines for NSQ drugs. The committee is to be ready with its report within three months, it is learnt.
According to sources, the recent meeting of DCC had taken note of the need for a fresh NSQ drug guideline. It had also condemned the slow enforcement of NSQ guidelines by several state drug controllers. They felt that several drug controllers are slow in taking action against NSQ manufacturer for a long period. The DCC had wanted all state drug controllers to intimate the action taken against the NSQ manufacturer within six months after receiving the test reports.
( Ref : Chronicle Pharmabiz dated July 28, 2005)